Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by increasing tetrahydrobiopterin via regulation of GTP-cyclohydrolase 1 and reducing uncoupled endothelial nitric oxide synthase activity

Atherosclerosis. 2021 Jul:328:83-91. doi: 10.1016/j.atherosclerosis.2021.05.019. Epub 2021 May 31.

Abstract

Background and aims: The apolipoprotein A-I mimetic peptide D-4F, among its anti-atherosclerotic effects, improves vasodilation through mechanisms not fully elucidated yet.

Methods: Low-density lipoprotein (LDL) receptor null (LDLr-/-) mice were fed Western diet with or without D-4F. We then measured atherosclerotic lesion formation, endothelial nitric oxide synthase (eNOS) phosphorylation and its association with heat shock protein 90 (HSP90), nitric oxide (NO) and superoxide anion (O2•-) production, and tetrahydrobiopterin (BH4) and GTP-cyclohydrolase 1 (GCH-1) concentration in the aorta. Human umbilical vein endothelial cells (HUVECs) and aortas were treated with oxidized LDL (oxLDL) with or without D-4F; subsequently, BH4 and GCH-1 concentration, NO and O2•- production, eNOS association with HSP90, and endothelium-dependent vasodilation were measured.

Results: Unexpectedly, eNOS phosphorylation, eNOS-HSP90 association, and O2•- production were increased, whereas BH4 and GCH-1 concentration and NO production were reduced in atherosclerosis. D-4F significantly inhibited atherosclerosis, eNOS phosphorylation, eNOS-HSP90 association, and O2•- generation but increased NO production and BH4 and GCH-1 concentration. OxLDL reduced NO production and BH4 and GCH-1 concentration but enhanced O2•- generation and eNOS association with HSP90, and impaired endothelium-dependent vasodilation. D-4F inhibited the overall effects of oxLDL.

Conclusions: Hypercholesterolemia enhanced uncoupled eNOS activity by decreasing GCH-1 concentration, thereby reducing BH4 levels. D-4F reduced uncoupled eNOS activity by increasing BH4 levels through GCH-1 expression and decreasing eNOS phosphorylation and eNOS-HSP90 association. Our findings elucidate a novel mechanism by which hypercholesterolemia induces atherosclerosis and D-4F inhibits it, providing a potential therapeutic approach.

Keywords: Apolipoprotein A–I mimetic peptide; Atherosclerosis; Endothelial nitric oxide synthase; GTP-Cyclohydrolase 1; Heat shock protein 90; Tetrahydrobiopterin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoprotein A-I
  • Atherosclerosis* / drug therapy
  • Atherosclerosis* / prevention & control
  • Biopterins / analogs & derivatives
  • Endothelial Cells
  • Endothelium, Vascular
  • GTP Cyclohydrolase
  • Guanosine Triphosphate
  • Mice
  • Nitric Oxide
  • Nitric Oxide Synthase Type III*
  • Peptides
  • Superoxides

Substances

  • Apolipoprotein A-I
  • Peptides
  • Superoxides
  • Biopterins
  • Nitric Oxide
  • Guanosine Triphosphate
  • Nitric Oxide Synthase Type III
  • GTP Cyclohydrolase
  • sapropterin